Arrow Financial Corporation
NASDAQ:AROWBanks - Regional
+$0.10 today
- Market cap
- $689.14M
- Beta
- 0.76
- P/E (TTM)
- 12.4
- EPS (TTM)
- $3.12
- Dividend yield
- 3.06%
Volume 0.07M
Average 0.08M
AROW Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Arrow Financial CorporationNASDAQ: AROW
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AROW compares with its peers on the latest reported figures
- AROW's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for AROW, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AROW) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for AROW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 147.92M | 160.55M | 191.68M | 223.07M | 242.58M |
| Cost of Revenue | 5.47M | 16.11M | 61.11M | 88.44M | 84.26M |
| Gross Profit | 142.45M | 144.44M | 130.57M | 134.63M | 158.32M |
| Gross Margin | 96.3% | 90.0% | 68.1% | 60.4% | 65.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 46.92M | 49.37M | 50.89M | 56.74M | 84.84M |
| Operating Expenses | 78.05M | 81.53M | 93.05M | 97.27M | 102.93M |
| Depreciation & Amortization | 7.83M | 7.55M | 6.72M | 5.36M | 5.42M |
| EBITDA | 72.23M | 70.46M | 44.24M | 42.72M | 60.81M |
| EBITDA Margin | 48.8% | 43.9% | 23.1% | 19.2% | 25.1% |
| Operating Income | 64.4M | 62.91M | 37.52M | 37.36M | 55.39M |
| Operating Margin | 43.5% | 39.2% | 19.6% | 16.7% | 22.8% |
| Interest Income | 115.55M | 129.65M | 162.56M | 194.99M | 210.15M |
| Interest Expense | 5.2M | 11.31M | 57.73M | 83.26M | 76.98M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 64.4M | 62.91M | 37.52M | 37.36M | 55.39M |
| Pre-Tax Margin | 43.5% | 39.2% | 19.6% | 16.7% | 22.8% |
| Income Tax Expense | 14.55M | 14.11M | 7.45M | 7.65M | 11.44M |
| Net Income | 49.86M | 48.8M | 30.08M | 29.71M | 43.95M |
| Net Margin | 33.7% | 30.4% | 15.7% | 13.3% | 18.1% |
| EPS (Basic) | 2.93 | 2.87 | 1.77 | 1.78 | 2.66 |
| EPS (Diluted) | 2.92 | 2.86 | 1.77 | 1.77 | 2.65 |
| Weighted Avg Shares | 16.99M | 17.01M | 17.04M | 16.74M | 16.5M |
| Weighted Avg Shares (Diluted) | 17.05M | 17.06M | 17.04M | 16.75M | 16.51M |
Arrow Financial Corporation
NASDAQ:AROW
Intrinsic Alpha fair value
Locked
Current Price
$37.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.